• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Thermo Fisher, West China Hospital Partner for precision medicine

Thermo Fisher, West China Hospital Partner for precision medicine

June 14, 2016
CenterWatch Staff

Thermo Fisher Scientific and West China Hospital of Sichuan University, one of the largest single-site hospitals in the world, have partnered to develop a joint platform to research precision medicine.

"Our company mission—to enable our customers to make the world healthier, cleaner and safer —is perfectly aligned with the priorities in China's 5-year plan," said Marc N. Casper, president and chief executive officer of Thermo Fisher. "We share a commitment to advancing precision medicine, and we're excited about strengthening our collaboration with West China Hospital to provide technologies and expertise that will ultimately improve patient care."

“We are exploring opportunities to collaborate with renowned, industry-leading international companies to harness and capitalize on our strength in pathology,” said Li Weimin, president of West China Hospital. “With our partners at Thermo Fisher, we are working to enhance the quality of pathological research and clinical diagnosis. We are also exploring an opportunity to extend our partnership in Western China by accelerating the development of precise pathological diagnoses that will ultimately help improve people’s lives.”

Richard Stengel, U.S. undersecretary of state for public diplomacy and public affairs, said, “In recent years, we have witnessed several achievements resulting from public and private partnerships between the U.S. and China—all of which aim to improve the well-being of people in both countries. The collaboration between Thermo Fisher and West China Hospital is a perfect example of America’s efforts to strengthen ties with China in science, technology and health. The agreement reinforces the spirit and goals of the CPE.”

The two parties have agreed to collaborate closely to make West China Hospital a leading global molecular diagnosis center. The joint efforts include construction of training bases for standardized pathology quality-control and standardized pathologic diagnosticians and the development of advanced laboratories with efficient, safe and integrated business procedures.

Upcoming Events

  • 24May

    Powering an Effective Oversight Strategy with Clinical and Operational Insights

  • 25May

    2022 WCG Avoca Quality & Innovation Summit: Own the Future

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing